AllianceBernstein’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,494,341
| Closed | -$61.1M | – | 3286 |
|
|
2024
Q2 | $61.1M | Buy |
1,494,341
+321,454
| +27% | +$13.1M | 0.02% | 549 |
|
|
2024
Q1 | $49.6M | Buy |
1,172,887
+40,247
| +4% | +$1.7M | 0.02% | 603 |
|
|
2023
Q4 | $48M | Buy |
1,132,640
+1,042,100
| +1,151% | +$44.2M | 0.02% | 595 |
|
|
2023
Q3 | $1.98M | Hold |
90,540
| – | – | ﹤0.01% | 1886 |
|
|
2023
Q2 | $2.88M | Buy |
90,540
+23,340
| +35% | +$742K | ﹤0.01% | 1699 |
|
|
2023
Q1 | $1.64M | Hold |
67,200
| – | – | ﹤0.01% | 1987 |
|
|
2022
Q4 | $2.12M | Hold |
67,200
| – | – | ﹤0.01% | 1884 |
|
|
2022
Q3 | $1.9M | Buy |
67,200
+4,400
| +7% | +$124K | ﹤0.01% | 1920 |
|
|
2022
Q2 | $1.66M | Buy |
62,800
+13,400
| +27% | +$354K | ﹤0.01% | 2056 |
|
|
2022
Q1 | $1.73M | Sell |
49,400
-25,054
| -34% | -$877K | ﹤0.01% | 2164 |
|
|
2021
Q4 | $2.41M | Buy |
74,454
+16,324
| +28% | +$529K | ﹤0.01% | 2015 |
|
|
2021
Q3 | $1.72M | Buy |
58,130
+26,100
| +81% | +$770K | ﹤0.01% | 2239 |
|
|
2021
Q2 | $821K | Buy |
+32,030
| New | +$821K | ﹤0.01% | 2605 |
|